Yongxu Mu
Overview
Explore the profile of Yongxu Mu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao J, Gong L, Xu Q, Wang J, Yang Y, Zhang S, et al.
Adv Mater
. 2024 Apr;
36(26):e2402445.
PMID: 38583077
Brain disorders represent a significant challenge in medical science due to the formidable blood-brain barrier (BBB), which severely limits the penetration of conventional therapeutics, hindering effective treatment strategies. This review...
2.
Wu X, Ma Z, Yang Y, Mu Y, Wu D
Stem Cell Res Ther
. 2023 Dec;
14(1):360.
PMID: 38087382
Background: Safety evaluations in preclinical studies are needed to confirm before translating a cell-based product into clinical application. We previously developed a serum-free, xeno-free, and chemically defined media (S&XFM-CD) for...
3.
Mu Y, Tong J, Wang Y, Yang Y, Wu X
Front Immunol
. 2023 Jul;
14:1213161.
PMID: 37457710
Adoptive transfer of natural killer (NK) cells represents a viable treatment method for patients with advanced malignancies. Our team previously developed a simple, safe, and cost-effective method for obtaining high...
4.
Ma Q, Mu Y, Gong L, Zhu C, Di S, Cheng M, et al.
Front Bioeng Biotechnol
. 2022 Nov;
10:1053872.
PMID: 36338143
As a highly pathogenic avian influenza virus, influenza A (H5N1) has been reported to infect humans, posing a major threat to both poultry industry and public health. It is an...
5.
Gong L, Wang C, Xu P, Gong J, Zhu C, Di S, et al.
ACS Appl Mater Interfaces
. 2022 Aug;
14(35):40266-40275.
PMID: 35983858
Bioresponsive nanomaterials are increasingly important in a variety of applications such as disease imaging, drug delivery, and tissue engineering. However, it remains a big challenge to manipulate response efficacy of...
6.
Wu X, Mu Y, Yao J, Lin F, Wu D, Ma Z
Front Cell Dev Biol
. 2022 Mar;
10:822772.
PMID: 35252190
Adipose-derived stem cells (ADSCs) are able to modulate the immune response and are used for treating ulcerative colitis (UC). However, it is possible that ADSCs from patients with inflammatory or...
7.
Wu X, Wu D, Mu Y, Zhao Y, Ma Z
Front Bioeng Biotechnol
. 2020 Jul;
8:586.
PMID: 32671030
The usage of animal serum may ultimately prevent the application of cultured mesenchymal stromal cells (MSCs) in a clinical setting due to safety concerns and batch-to-batch variability. Increasing regulatory pressure...
8.
Mu Y, Wu X, Hao Z
BMC Cell Biol
. 2018 Dec;
19(1):27.
PMID: 30545286
Background: Within the past years, umbilical cord (UC) and amniotic membrane (AM) expanded in human platelet lysate (PL) have been found to become increasingly candidate of mesenchymal stromal cells (MSCs)...
9.
Mu Y, Yan R, He J, Hu X, Li Q, Liu H
Pak J Med Sci
. 2016 Nov;
32(5):1082-1086.
PMID: 27881998
Objective: To compare the effects of MRI- and CT-guided interventional therapies on uterine fibroids. Methods: A total of 280 patients with uterine fibroids who were treated in our hospital from...
10.
Mu Y, Hao Z, He J, Yan R, Liu H, Zhang L, et al.
Artif Cells Nanomed Biotechnol
. 2016 Jun;
44(5):1333-8.
PMID: 27328726
Exogenous insulin and EGFP genes were transduced into bone marrow mesenchymal stem cells of beagle dogs using the retroviral vector pMSCV to prepare β-like cells. These cells were autotransplanted into...